Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.970
-0.130 (-6.19%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Metagenomi Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Metagenomi stock have an average target of 15.5, with a low estimate of 6.00 and a high estimate of 25. The average target predicts an increase of 686.80% from the current stock price of 1.97.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Metagenomi stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +255.33% | Oct 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +255.33% | Sep 6, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +661.42% | Sep 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +255.33% | Aug 21, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $17 → $15 | Strong Buy | Maintains | $17 → $15 | +661.42% | Aug 19, 2024 |
Financial Forecast
Revenue This Year
44.93M
from 44.76M
Increased by 0.39%
Revenue Next Year
34.13M
from 44.93M
Decreased by -24.03%
EPS This Year
-2.99
from -20.05
EPS Next Year
-2.93
from -2.99
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 64.1M | 73.5M | 131.5M |
| Avg | 44.9M | 34.1M | 39.6M |
| Low | 33.0M | 9.8M | 9.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 43.1% | 63.6% | 285.1% |
| Avg | 0.4% | -24.0% | 16.0% |
| Low | -26.2% | -78.2% | -71.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.49 | -1.05 | -0.23 |
| Avg | -2.99 | -2.93 | -2.20 |
| Low | -3.43 | -3.82 | -3.53 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.